NCT03896906 is a NA clinical trial of High-flow nasal cannula in Head and Neck Neoplasm, sponsored by Asan Medical Center.

Who is sponsoring NCT03896906?

NCT03896906 is sponsored by Asan Medical Center.

What drugs are being tested in NCT03896906?

Interventions in NCT03896906: High-flow nasal cannula, simple mask.

What condition does NCT03896906 study?

NCT03896906 studies Head and Neck Neoplasm.

Is NCT03896906 still recruiting?

NCT03896906 is currently completed. Last updated 7 May 2020.

Last reviewed 2020-05-07 · How we verify

NCT03896906

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surgery

Completed NA Last updated 7 May 2020

What this trial tests

NA trial testing High-flow nasal cannula in Head and Neck Neoplasm in 52 participants. Completed in 7 April 2020.

Timeline

8 May 2019

Primary endpoint
7 April 2020

7 April 2020

Quick facts

Lead sponsor	Asan Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	52
Start date	8 May 2019
Primary completion	7 April 2020
Estimated completion	7 April 2020
Sites	1 location across South Korea

Drugs / interventions tested

High-flow nasal cannula
simple mask

Conditions studied

Head and Neck Neoplasm — all drugs for Head and Neck Neoplasm →

Sponsor

Asan Medical Center

Who can join

Adults 19 to 80, any sex, with Head and Neck Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: To assess arterial oxygen partial pressure (PaO2) at defined time points during the preoxygenation and to compare between high ﬂow heated humidified nasal oxygen versus standard preoxygenation with oxygen insufflation via face mask over at least 5 minutes Methods: This randomized, single-blinded, prospective study was conducted at Asan Medical Center in Seoul, Republic of Korea. Populations: Patients undergoing head and neck surgery Expected outcomes: The course of PaO2 levels is superior to those of the face mask during the whole preoxygenation procedure and after the intubation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Comparison of preoxygenation with a high-flow nasal cannula and a simple mask before intubation during induction of general anesthesia in patients undergoing head and neck surgery: Study protocol clinical trial (SPIRIT Compliant).
Jo JY, Kim WJ, Ku S, Choi SS. · · 2020 · cited 5× · PMID 32195955 · DOI 10.1097/md.0000000000019525
Comparison of preoxygenation with a high-flow nasal cannula and a simple face mask before intubation in Korean patients with head and neck cancer.
Jo JY, Yoon J, Jang H, Kim WJ, et al · · 2024 · PMID 38303582 · DOI 10.4266/acc.2022.01543

Verify or expand the search:

Other trials of High-flow nasal cannula

Trials testing the same drug.

NCT07155330 — High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients · NA · completed
NCT06663293 — Comparison of High Flow vs Standard Nasal Cannula in Children With Burns Under Sedoanalgesia · NA · completed
NCT05012696 — Physiological Effects of Non-invasive Mechanical Ventilation Versus High-flow Nasal Cannula in Critically Ill Patients a · NA · completed
NCT04507425 — High Flow Nasal Cannula With Noninvasive Ventilation · NA · completed
NCT04471220 — Exercise Capacity Under Various FiO2 and Oxygen Flow Rates Using HFNC · NA · completed

Other recruiting trials for Head and Neck Neoplasm

Currently open trials in the same condition.

NCT04099290 — Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma · recruiting
NCT06356272 — Oropharynx (OPX) Biomarker Trial · recruiting
NCT04005521 — Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer · NA · active not recruiting
NCT03840421 — GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma · Phase 3 · active not recruiting

Other Asan Medical Center trials

Trials by the same sponsor.

NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03896906 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
Last refreshed: 7 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03896906.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing